Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Lung cancer:

About the author: 

Lung cancer patients are usually prescribed either Tarceva (erlotinib) or Iressa (glefitinib)

Lung cancer patients are usually prescribed either Tarceva (erlotinib) or Iressa (glefitinib). Doctors will probably tell the unfortunate patient that the drugs stop the growth of the cancers by blocking the signaling from a molecule that's vital to the survival of the cancer cells.
What he may not mention is that the drugs are effective in only 10 per cent of patients, especially those with non-small cell lung cancer (NSCLC), which is often contracted by non-smokers. And after a while, they are not effective at all - and, in fact, encourage the growth of the cancer.
Oncologists know that the drugs seem to trigger fresh tumour growth, which is known as acquired or secondary resistance, but researchers are trying to figure out why this phenomenon occurs.
They tracked six NSCLC patients who were given the drugs, and three developed fresh tumours.
They weren't able to establish why the tumours develop such a virulent resistance to the drugs, but were able to confirm that the new mutations contained gene variants that "they had come across before". So that's a relief.


Fractures:

Pyogenic granuloma:

You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved